In addition, calcitonin reduced MDA and ROS levels, but elevated SOD and ATP activities in the cerebral cortex of CKD mice, while upregulated Drp1 significantly reversed the effect of calcitonin on mitochondria in cerebral cortex of CKD mice (Fig. 3E–I). This evidence concerns the gene DNM1L and chronic kidney disease.